Raderer M et al. |
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. |
2000 |
Gut |
pmid:10601069
|
Sainz R et al. |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. |
1999 |
Rev Esp Enferm Dig |
pmid:10601771
|
Tanaka G et al. |
Effect of clarithromycin on Pseudomonas aeruginosa biofilms. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601796
|
Hamada K et al. |
Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601798
|
Fernández-Roblas R et al. |
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602744
|
Ku YY et al. |
Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. |
1999 |
J. Antibiot. |
pmid:10604761
|
Ianaro A et al. |
Anti-inflammatory activity of macrolide antibiotics. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10604943
|
Suzuki K et al. |
Effect of proton pump inhibitor alone or in combination with clarithromycin on mycobacterial growth in human alveolar macrophages. |
2000 |
FEMS Microbiol. Lett. |
pmid:10612733
|
Giacometti A et al. |
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10614961
|
Midolo PD et al. |
In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10614963
|
Abe S et al. |
Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. |
2000 |
Am. J. Respir. Cell Mol. Biol. |
pmid:10615065
|
Kiyota K et al. |
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial. |
1999 |
J. Gastroenterol. |
pmid:10616771
|
Aoyama N et al. |
Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers. |
1999 |
J. Gastroenterol. |
pmid:10616772
|
Gotoda T et al. |
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. |
1999 |
J. Gastroenterol. |
pmid:10616774
|
Maeda S et al. |
Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay. |
2000 |
J. Clin. Microbiol. |
pmid:10618089
|
Rocha RT et al. |
Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections. |
1999 |
Int. J. Clin. Pract. |
pmid:10622070
|
Lugannani C and Strickland C |
Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients? |
1999 |
J Fam Pract |
pmid:10628582
|
Bui KQ et al. |
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. |
2000 |
J. Antimicrob. Chemother. |
pmid:10629013
|
Blondon H |
[Eradication of Helicobacter pylori: what is the effect on symptoms of non-ulcerous dyspepsia?]. |
1999 |
Presse Med |
pmid:10629694
|
Cammarota G et al. |
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection. |
1999 |
Dig. Dis. Sci. |
pmid:10630486
|